Cargando…
Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress
OBJECTIVE: With the increasing incidence of diabetes mellitus (DM) combined with myocardial ischemia, how to reduce myocardial ischemia-reperfusion injury in DM patients has become a major problem faced by clinicians. We investigated the therapeutic effects of dexmedetomidine (DEX) on myocardial isc...
Autores principales: | Li, Jinjie, Zhao, Ying, Zhou, Nan, Li, Longyun, Li, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914963/ https://www.ncbi.nlm.nih.gov/pubmed/31886285 http://dx.doi.org/10.1155/2019/7869318 |
Ejemplares similares
-
Dexmedetomidine Attenuates Ischemia/Reperfusion-Induced Myocardial Inflammation and Apoptosis Through Inhibiting Endoplasmic Reticulum Stress Signaling
por: Yang, Yu-fan, et al.
Publicado: (2021) -
Naringin attenuates cerebral ischemia-reperfusion injury in rats by inhibiting endoplasmic reticulum stress
por: Wang, Li, et al.
Publicado: (2021) -
Attenuation of endoplasmic reticulum stress as a treatment strategy against ischemia/reperfusion injury
por: Lin, Chih-Li
Publicado: (2015) -
Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021) -
Protective Effect of Sufentanil on Myocardial Ischemia-Reperfusion Injury in Rats by Inhibiting Endoplasmic Reticulum Stress
por: Qiu, Liuji, et al.
Publicado: (2022)